These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 20823835)
1. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Ellis L; Shale MJ; Coleman MP Am J Gastroenterol; 2010 Dec; 105(12):2563-9. PubMed ID: 20823835 [TBL] [Abstract][Full Text] [Related]
2. A 5-decade analysis of 13,715 carcinoid tumors. Modlin IM; Lye KD; Kidd M Cancer; 2003 Feb; 97(4):934-59. PubMed ID: 12569593 [TBL] [Abstract][Full Text] [Related]
3. Updated population-based review of carcinoid tumors. Maggard MA; O'Connell JB; Ko CY Ann Surg; 2004 Jul; 240(1):117-22. PubMed ID: 15213627 [TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship? McCarthy DM Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924 [TBL] [Abstract][Full Text] [Related]
5. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. Ito T; Sasano H; Tanaka M; Osamura RY; Sasaki I; Kimura W; Takano K; Obara T; Ishibashi M; Nakao K; Doi R; Shimatsu A; Nishida T; Komoto I; Hirata Y; Nakamura K; Igarashi H; Jensen RT; Wiedenmann B; Imamura M J Gastroenterol; 2010 Feb; 45(2):234-43. PubMed ID: 20058030 [TBL] [Abstract][Full Text] [Related]
6. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665 [TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal carcinoids: an increasing incidence of rectal distribution. Avenel P; McKendrick A; Silapaswan S; Kolachalam R; Kestenberg W; Ferguson L; Jacobs MJ; Goriel Y; Mittal V Am Surg; 2010 Jul; 76(7):759-63. PubMed ID: 20698387 [TBL] [Abstract][Full Text] [Related]
9. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. Ito T; Igarashi H; Nakamura K; Sasano H; Okusaka T; Takano K; Komoto I; Tanaka M; Imamura M; Jensen RT; Takayanagi R; Shimatsu A J Gastroenterol; 2015 Jan; 50(1):58-64. PubMed ID: 24499825 [TBL] [Abstract][Full Text] [Related]
10. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study. Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS PLoS One; 2013; 8(4):e62487. PubMed ID: 23614051 [TBL] [Abstract][Full Text] [Related]
11. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156 [TBL] [Abstract][Full Text] [Related]
12. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study. Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541 [TBL] [Abstract][Full Text] [Related]
13. Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in Switzerland. Alwan H; La Rosa S; Andreas Kopp P; Germann S; Maspoli-Conconi M; Sempoux C; Bulliard JL Cancer Med; 2020 Dec; 9(24):9454-9461. PubMed ID: 33078908 [TBL] [Abstract][Full Text] [Related]
14. The epidemiology of carcinoid tumours in England and Scotland. Newton JN; Swerdlow AJ; dos Santos Silva IM; Vessey MP; Grahame-Smith DG; Primatesta P; Reynolds DJ Br J Cancer; 1994 Nov; 70(5):939-42. PubMed ID: 7947101 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia. Wyld D; Wan MH; Moore J; Dunn N; Youl P Cancer Epidemiol; 2019 Dec; 63():101598. PubMed ID: 31539715 [TBL] [Abstract][Full Text] [Related]
16. Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease? Fitzgerald TL; Dennis SO; Kachare SD; Vohra NA; Zervos EE Surgery; 2015 Aug; 158(2):466-71. PubMed ID: 26013986 [TBL] [Abstract][Full Text] [Related]
17. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Hemminki K; Li X Cancer; 2001 Oct; 92(8):2204-10. PubMed ID: 11596039 [TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Hassan MM; Phan A; Li D; Dagohoy CG; Leary C; Yao JC Int J Cancer; 2008 Aug; 123(4):867-73. PubMed ID: 18491401 [TBL] [Abstract][Full Text] [Related]
19. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Yao JC; Hassan M; Phan A; Dagohoy C; Leary C; Mares JE; Abdalla EK; Fleming JB; Vauthey JN; Rashid A; Evans DB J Clin Oncol; 2008 Jun; 26(18):3063-72. PubMed ID: 18565894 [TBL] [Abstract][Full Text] [Related]
20. Carcinoid tumours in the gastrointestinal tract--a population-based study from Western Norway. Helland SK; Prøsch AM; Viste A Scand J Surg; 2006; 95(3):158-61. PubMed ID: 17066609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]